SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-460669
Filing Date
2012-11-08
Accepted
2012-11-08 16:55:02
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398107d10q.htm 10-Q 570318
2 EX-31.1 d398107dex311.htm EX-31.1 10151
3 EX-31.2 d398107dex312.htm EX-31.2 10331
4 EX-32 d398107dex32.htm EX-32 4185
  Complete submission text file 0001193125-12-460669.txt   2890767

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pvct-20120930.xml EX-101.INS 285852
6 XBRL TAXONOMY EXTENSION SCHEMA pvct-20120930.xsd EX-101.SCH 40952
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvct-20120930_cal.xml EX-101.CAL 44762
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvct-20120930_def.xml EX-101.DEF 110707
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvct-20120930_lab.xml EX-101.LAB 270620
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvct-20120930_pre.xml EX-101.PRE 185648
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS PHARMACEUTICALS INC (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-09410 | Film No.: 121190675
SIC: 2834 Pharmaceutical Preparations